2018 SPEAKERS

 

 

Dr Dicky Abraham, Executive Director, Project Leadership Group, Global Vaccine and Biologics Commercialization, Merck, United States

Anup Akkihal, Chief Executive, Logistimo, India

Dr Carl Alving, Former Chief of Adjuvant and Antigen Research & Emeritus Senior Scientist, Walter Reed Army Institute Of Research, United States

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer, United States

Marty Anderson, Executive Director, Clinical Development - GenMed, Syneos Health, United States

Marty Anderson at World Vaccine Congress Washington 2018

Dr Philip Arlen, President and Chief Executive Officer, Precision Biologics Inc, United States

Dr Bo Arve, Executive Director, Pfizer, United States

Dr Bo Arve at World Vaccine Congress Washington 2018

Prof Fikri Avci, Academy, UGA Center for Molecular Medicine, United States

Dr Allan B Dietz, Director, Immune, Progenitor, and Cell Therapeutics (IMPACT), Division of Transfusion Medicine, Mayo Clinic and Foundation, United States

Dr Wilfried Bakker, Program Manager Viral Vaccines, Intravacc, Sweden

Dr Ripley Ballou, VP & Head, GSK Global Vaccines US R&D Center, GSK Vaccines, Belgium

Dr Ripley Ballou at World Vaccine Congress Washington 2018

Ms Emily Bancroft, President, VillageReach, United States

Dr Eliav Barr, Senior Vice President, Infectious Diseases and Vaccines Clinical Development, Merck Research Laboratories, United States

Dr Samik Basu, Director of Translational Sciences, Adaptimmune Llc, United States

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories, United States

Dr Wolfgang Bender, Chief Medical Officer, Valneva, France

Jason Berg, Director, Project Management, PPD, United States

Jason Berg at World Vaccine Congress Washington 2018

Franck Berthe, Senior Livestock Specialist, The World Bank, United States

Dr Jay A. Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH, United States

Dr Nina Bhardwaj, Director of Immunotherapy Professor of Medicine, Division of Hematology & Oncology, Tisch Cancer Institute, United States

Dr Todd Black, Executive Director, Infectious Diseases, Merck Research Laboratory, United States

Dr Steven Black, Professor of Pediatrics, Center for Global Health, University of Cincinnati Children’s Hospital in Ohio, United States of America

Dr David Bloom, Professor of Economics and Demography, Harvard T.H. Chan School of Public Health, United States

Dr Bahram Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics, United States

Dr Karin Bok, Senior Vaccine Science Advisor, US Department of Health and Human Services, United States

Dr Ezio Bonvini, CSO, MacroGenics, Inc., United States

Dr Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine, United States

Dr Karen Broder, Medical Officer, US Centers for Disease Control and Prevention, United States

Jennifer Brogdon, Director of Exploratory Immuno Oncology, N.I.B.R., United States

Matthew Burt, Vaccine Supply Chain Director,, Pfizer, United States

Lynlee Burton, Director of Project Delivery - Vaccines, PRA Health Sciences, United States

Dr Andrea Carfi, Senior Director, Antigen Design and Project Leader, Valera LLC, Italy

Dr Andrea Carfi at World Vaccine Congress Washington 2018

Dr Corey Casper, Chief Scientific Officer, Infectious Disease Research Institute, United States

Dr Cristina Cassetti, Branch Chief Virology Branch Division of Microbiology and Infectious Diseases, National Institutes of Health (NIH), United States

Andrew Catchpole, Scientific and Operations Director, hVIVO, United Kingdom

Dr Jean-Charles Cavitte, Research Policy Officer, European Commission, Belgium

Dr Jean-Charles Cavitte at World Vaccine Congress Washington 2018

Dr Sumana Chandramouli, Laboratory Head, Preclinical R&D, GSK Vaccines, United States

Dr Sumana Chandramouli at World Vaccine Congress Washington 2018

Dr Pierre Charneau, Head, TheraVectys-Institut Pasteur Joint-Lab, France

Dr Grace Chen, Deputy Chief, National Institutes of Health, United States

Dr KC Cheng, Senior Director - Analytical and Formulation Development, NIAID, NIH & University of Kansas, United States

James Cheyne, Independent Supply Chain Consultant Co-Founder of WHO's Cold Chain Unit, Health Service Logistics, Switzerland

Dr Roman Chicz, Associate Vice President and Global Head Of External Research and Development, Sanofi Pasteur, United States

Mohit Chopra, Senior Manager of USOTC Supply Chain Strategic Improvement, Johnson & Johnson, United States

Dr Giuseppe Ciaramella, Chief Scientific Officer, Infectious Diseases, Moderna Therapeutics, United States

Dr Michael Ciesielski, Assistant Professor of Neurosurgery & Oncology, Roswell Park Cancer Institute, United States

William Conklin, Value Chain Leader, Merck Vaccines, United States

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics, United States

Dr Andrew Cox, Senior Research Officer, National Research Council, Canada

Dr Andrew Cox at World Vaccine Congress Washington 2018

Ms Rebecca Coyle, Executive Director, American Immunization Registry Association, United States

Dr Alan Cross, Professor of Medicine, University of Maryland School of Medicine, United States

Dr James Crowe, Director of Vanderbilt Vaccine Center, Vanderbilt Vaccine Center, United States

Dr Ildiko Csiki, Vice President - Clinical Development, Inovio Pharmaceuticals, United States

Dr James Cummings, Vice President, Clinical Development and Translational Medicine, Novavax, United States

Dr Margie Danchin, Paediatrcian and Senior Research Fellow, Murdoch Children's Research Institute, Royal Children's Hospital, United States

Giuseppe Del Giudice, Translational Science Leader, GSK, Italy

Dr Philippe Denoel, Director of External R and D, Innovation, Scientific Affairs and Opportunities Collaborations for Public Funding, GSK Vaccines, Belgium

Dr Philippe Denoel at World Vaccine Congress Washington 2018

Dr Francisco Diaz-Mitoma, Chief Medical Officer, VBI Vaccines, United States

Dr Arnaud Didierlaurent, Head Adjuvant Platform, GSK Vaccines, Belgium

Dr Arnaud Didierlaurent at World Vaccine Congress Washington 2018

Dr Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc, United States

Dr Ruben Donis, Deputy Director of the Division of Influenza and Emerging Infectious Diseases, HHS - ASPR - BARDA, United States

Dr Philip Dormitzer, Vice President and CSO, Viral Vaccines, Pfizer, United States

Matthew Duchars, VP, Product Development, Emergent BioSolutions, United States

Dr Cynthia Dukes, Vice President - Global Project Management, ICON, United States

Dr Peter Dull, Deputy Director, Integrated Clinical Vaccine Development, The Bill & Melinda Gates Foundation, United States

Dr Ruth Faden, Founder, Johns Hopkins Berman Institute of Bioethics, United States

Dr Ruth Faden at World Vaccine Congress Washington 2018

Nima Farzan, Chief Executive Officer, PaxVax Inc, United States

Nima Farzan at World Vaccine Congress Washington 2018

Heinz Feldmann, Chief, Laboratory of Virology Chief, Disease Modeling and Transmission Section, NIH, United States

Dr Benjamin Fiebiger, Senior Scientist, Lead Immunologist, Siolta Therapeutics, United States

Amy Finan, Chief Executive Officer, Sabin Vaccine Institute, United States

Dr Veronica Gambillara Fonck, Co-Founder & Chief Executive Officer, LimmaTech Biologics AG, Switzerland

Dr Cyril G Gay, Senior National Program Leader, A.R.S. National Programs, United States

Parrish Galliher, Chief Technology Officer, GE Healthcare, United States

Dr Nathalie Garcon, CEO/CSO, BIOASTER, Belgium

Professor Thomas Geisbert, Professor Microbiology and Immunology, University of Texas Medical Branch, United States

Dr Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute, United States

Dr Don Gerson, CEO, Pnuvax Inc, Canada

Dr Brad Gessner, VP for Scientific Affairs at AMP, Faculty at U. Maryland/Centers for Vaccine Development & VP and Director, Global Pneumococcal, Pfizer, United States

Dr Ahmad Ghoniem, Manager of Sales and Business Development, tesa Labtec, Germany

Dr Basav Ghosh, Sr. Director, Pfizer, United States

Jeremy Gillespie, Global sales Director, Kerry, United Kingdom

Dr Ann Ginsberg, Chief Medical Officer, AERAS, United States

Geoffrey Glauser, Senior Consultant Supply Chain, HHS - ASPR - BARDA, United States

Dr Gregory Glenn, President, Research and Development, Novavax, United States

Dr Barney Graham, Deputy Director of Vaccine Research Center, National Institute of Allergy and Infectious Diseases, United States

Dr Duane J Gubler, Emeritus Professor, Programme in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore

Dr Farshad Guirakhoo, CSO, GeoVax, Inc., United States

Dr Nir Hacohen, Director of the Center for Cancer Immunology and Co-Director of the Center for Cell Circuits, Broad Institute and Massachusetts General Hospital, United States

Dr Neal Halsey, Professor of International Health, Director of the Institute for Vaccine Safety, Johns Hopkins, United States

Dr Scott Halstead, Adjunct Professor, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, United States

Dr Ahd Hamidi, Project Director, Batavia Biosciences, Netherlands

Paddy Hanlon, V.P. Global Key Accounts, Marken, United States

Dr Mazen Hassanain, Founder, SaudiVax, Saudi Arabia

Charles Heffernan, Former Supply Chain Transformation and Technology Innovation Lead, GSK & Member, BioPhorum Operations Group, United Kingdom

Ana Maria Henao Restrepo, Implementation Research and Economic Analysis, Initiative for Vaccine Research, World Health Organization, Switzerland

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited, United Kingdom

Marc Hoffman, CMO, Celerion, Germany

Dr Wayne Hogrefe, VP, Vaccines, Q² Solutions, United States

Dr Peter Hotez, Dean, National School of Tropical Medicine, Director, Texas Children’s Hospital Center, Baylor College of Medicine, United States

Dr John A. Howard, President, Applied Biotechnology Institute, United States

Dr Ken Ishii, Professor and Project Leader, Osaka U.i, Japan

Dr Hector Izurieta, Epidemiologist, Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER, U.S. Federal Drug Administration, United States

Reggie Jackson, Senior Manager of Supply Chain Security, Pfizer, United States

Julie Jacobson, Senior Program Officer, Neglected Tropical Diseases, The Bill & Melinda Gates Foundation, United States

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology, United States

Dr Jorge Kalil, Former director of Butantan Institute, Professor and Head Clinical Immunology, School of Medicine, University Of Sao Paulo, Brazil

Dr Jorge Kalil at World Vaccine Congress Washington 2018

Dr Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly and Company, United States

Kemal Karaca, Director, Elanco Animal Health, United States

Dr Erin Karski, Associate Medical Director, Genentech, United States

Dr Cheryl Keech, Executive Medical Director, PPD, United States

Peter Khoury, CEO, Ology Bioservices, United States

Peter Khoury at World Vaccine Congress Washington 2018

Wayne C Koff, President and CEO, The Human Vaccines Project, United States

Camille Kotton, Clinical Director, Transplant and Immunocompromised Host Infectious Diseases, Massachusetts General Hospital, United States

Dr Lakshmi Krishnan, Group Leader-Senior Research Officer, National Research Council, Canada

Dr Carleigh Krubiner, Research Scholar, Johns Hopkins Berman Institute of Bioethics, United States

Dr Carleigh Krubiner at World Vaccine Congress Washington 2018

Dr Mahesh Kumar, Vice President, Global Biologics Research, Zoetis, United States

Dr Peter Kwong, Chief, Structural Biology Section, NIH, United States

Dr Rhonda LaFleur, Principal Scientist, Merck Animal Health, United States

Dr Hans Langedijk, Director of Subunit Vaccine Design, Janssen Vaccines & Prevention B.V., Netherlands

Dr Heidi Larson, Professor of Anthropology, Risk and Decision Science, London School of Hygiene and Tropical Medicine, United Kingdom

Dr Stéphane Lemiere, Global Director of Technical Services, Boehringer Ingelheim France, France

Dr Ching Ching Leow, AVP, Immuno-Oncology Clinical Development, Eli Lilly and Company, United States

Dr Ching Ching Leow at World Vaccine Congress Washington 2018

Dr Myron M. Levine, Grollman Distinguished Professor and Director, Center for Vaccine Development, University of Maryland School of Medicine, United States

Dr Hyam Levitsky, Executive Vice President and Chief Scientific Officer, Juno Therapeutics, United States

Dr Fiona Lin, Small Molecule Analytical Chemistry and Quality Control, Genentech, United States

Thomas Lingelbach, President and Chief Executive Officer, Valneva, Austria

Dr Pascal Longchamp, Chief Corporate & Commercial Officer, Scarab Genomics, India

Dr Pascal Longchamp at World Vaccine Congress Washington 2018

Dr Ira Longini, Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida, United States

Dr Robin Löving, CSO, Salipro Biotech AB, Sweden

Dr Robin Löving at World Vaccine Congress Washington 2018

Dr Nicole Lurie, Strategic Advisor to CEO, CEPI, United States

Dr Natalie Mazur, Clinician-Investigator, Wilhelmina Children’s Hospital in Utrecht, Netherlands

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc., United States

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi, Italy

Prof James Moon, Assistant Professor of Biomedical Informatics, University of Michigan, United States

Dr Martin Moore, Associate Professor, Interim Director of Research, Pediatric Infectious Diseases, Emory University Children’s Center, United States

Dr Vasee Moorthy, Coordinator, Research, Ethics, Knowledge Uptake, Department of Information, Evidence and Research, & Team Leader, R&D Blueprint, World Health Organization, Denmark

Dr Alex Morrow, Chair of the International Research Consortium, STAR-IDAZ International Research Consortium on Animal Health, United Kingdom

Dr Sally Mossman, VP, Head Discovery Performance Unit, US, GSK Vaccines, United States

Wilhelm (Willie) Muehlhausen, VP eCOA & Innovation, ICON, United States

Wilhelm (Willie) Muehlhausen at World Vaccine Congress Washington 2018

Dr Thomas Muster, Managing Director and Chief Scientific Officer, Vivaldi Biosciences Inc, Austria

Dr Gary Nabel, Chief Scientific Officer & Senior Vice President Head, North America R&D Hub, Sanofi Pasteur, United States

Stephen Nagler, Executive Director, MedPro Investors LLC, United States

Stephen Nagler at World Vaccine Congress Washington 2018

Dr Eszter Nagy, Co-Founder, President and CSO, Arsanis Inc, Austria

Dr Christopher Nelson, AVP, Global Medical Affairs, Dengue, Sanofi Pasteur, France

Dr Christopher Nelson at World Vaccine Congress Washington 2018

Dr John Nieland, Chief Operating Officer, 2A Pharma, Sweden

Dr Paul Offit, Chief of Infectious Diseases, & Director of the Vaccine Education Center, Childrens Hospital of Pennsylvania, United States

Dr Derek O'Hagan, Global Head of Discovery Support and New Technology, GSK Vaccines, United States

Dr Saad B Omer, William H. Foege Professor of Global Health Professor of Epidemiology & Pediatrics, Emory University - School of Medicine, United States

Dr Walter A Orenstein, Professor and Associate Director, Emory Vaccine Center Emory University, United States

Dr Justin R Ortiz, Former Medical Officer, Initiative for Vaccine Research for WHO & Associate Professor of Medicine, University of Maryland, United States

Professor Klaus Osterrieder, Managing Director, Institute of Virology, Department of Veterinary Medicine, Freie Universitt Berlin, Germany

Dr Drew Pardoll, Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy Professor of Oncology, John Hopkins University, United States

Dr Raphael Pareschi, Pharmacovigilance Associate Director, PV Country lead deputy,, Merck & Co, Brazil

Ranjeet Patil, Global Segment Marketing Manager, MilliporeSigma, United States

Ranjeet Patil at World Vaccine Congress Washington 2018

Dr Viliam Pavliak, Head of Vaccine Development, International Vaccine Institute, Republic Of Korea

Dr Viliam Pavliak at World Vaccine Congress Washington 2018

Dr Franco Pissani, Vice President, Business Development & Scientific Advisor, Mabtech, United States

Dr Franco Pissani at World Vaccine Congress Washington 2018

Dr Lisa Plitnick, Senior Principal Scientist, Vaccines Therapeutic Area Lead, Safety Assessment and Laboratory Animal Resources, Merck Research Laboratories, United States

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine, United States

Dr Laurent Poirot, Head of Early Discovery, Cellectis, France

Dr Laurent Poirot, Head of Early Discovery, Cellectis, France

Dr Laurent Poirot at World Vaccine Congress Washington 2018

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation, United States

Dr Frederick Porter, Senior Director of Product Development, Duke Human Vaccine Institute, United States

Dr Andrew Potter, CEO, VIDO-InterVac, Canada

Dr Jean-Francois Poulin, Associate Director, Caprion Biosciences, Canada

Dr Steve Projan, Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious Diseases and Vaccines, MedImmune Inc, United States

Dr Hari Pujar, Vice President Technical Development and Manufacturing, Moderna Therapeutics, United States

Dr Fred Ramsdell, Vice President, Research, Parker Institute for Cancer Immunotherapy, United States

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines, United States

Dr Steven Reed, President, Founder & CEO, Infectious Disease Research Institute, United States

Dr Robert Reiner, Assistant Professor, Global Health, University Of Washington, United States

Dr Robert Reiner at World Vaccine Congress Washington 2018

Dr Arthur Reingold, Professor and Division Head Epidemiology, Former ACIP Member, UC Berkeley School of Public Health, United States

Felix Rey, Head of Structures, Institut Pasteur, France

Felix Rey at World Vaccine Congress Washington 2018

Dr Margo R. Roberts, Chief Scientific Officer, Kite Pharma Inc, United States

Dr Scot Roberts, Chief Scientific Officer, Altimmune, United States

Dr Scot Roberts at World Vaccine Congress Washington 2018

Dr Simona Rondini, Vaccine Development Lead, COPD Vaccine, GSK Vaccines, Italy

Jeffrey Rowland, Director, Global Operational Partnerships, Gavi, The Vaccine Alliance, Switzerland

Dr Dorit Rubinstein Reiss, Professor of Law, UC Hastings College of the Law, United States

Rodrigo Ruiz, Head of Country Pharmacovigilance Mexico, Bristol-Myers Squibb De Mexico, Mexico

Dr Clifford Sachs, Director, R&D Toxicology, MedImmune Inc, United States

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines, United States

Wendy Saffell-Clemmer, Director - Research, Baxter BioPharma Solutions, United States

Dr Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute, Republic Of Korea

Dr Sushant Sahastrabuddhe at World Vaccine Congress Washington 2018

Dr Daniel Salmon, Prof Global Disease Epidemiology and Control; Deputy Director JHU’s Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, United States

Surya Sankuratri, Executive Director, Merck, United States

Surya Sankuratri at World Vaccine Congress Washington 2018

Dr Mathuram Santosham, Professor, Johns Hopkins University, United States

Dr Mathuram Santosham at World Vaccine Congress Washington 2018

Dr Niranjan Sardesai, COO, Inovio Pharmaceuticals, United States

Beate Schmoele-Thoma, Senior Director Vaccine Clinical Research and Development, Clinical Lead, RSV, Pfizer, United States

Beate Schmoele-Thoma at World Vaccine Congress Washington 2018

Michael A. Schrader, Co-Founder and Chief Executive Officer, Vaxess Technologies, Inc, United States

Dr Jason Schwartz, Assistant Professor of Health Policy, Yale School of Public Health, United States

Dr Robert Seder, Chief of the Cellular Immunology Section, NIAID, NIH, United States

Dr Darin Seehafer, Clinical Scientist/Program Director, PRA Health Sciences, United States

Dr Alessandro Sette, Professor, Head and Member, La Jolla Infectious Disease Institute, United States

Dr Aiman Shalabi, Chief Medical Officer, Cancer Research Institute, United States

Dr Angela Shen, CAPT, US Public Health Service, Senior Science Policy Advisor, National Vaccine Program Office, U.S. Department of Health & Human Services, United States

Pei-Yong Shi, Kempner Professor of Human Genetics, University of Texas Medical Branch, United States

Dr Li Shi, Chief Executive Officer, Shanghai Zerun Biotechnology Co Ltd, China

Dr Sushma Shivaswamy, Vice President, Research and Development, XBiotech, United States

Dr George Siber, CSO of ClearPath Vaccines & Scientific Advisory Board of Genocea, ClearPath Vaccines, United States

Dr George Siber at World Vaccine Congress Washington 2018

Nigel Silman, Senior Business Development Manager, Public Health England, United Kingdom

Nigel Silman at World Vaccine Congress Washington 2018

Dr Raphael Simon, Assistant Professor of Medicine, University of Maryland School of Medicine, United States

Dr Rahul Singhvi, Chief Operating Officer, Takeda Vaccines, United States

B.T. Slingsby, Chief Executive Officer and Executive Director, Global Health Innovative Technology Fund, China

B.T. Slingsby at World Vaccine Congress Washington 2018

Dr David L. Smith, Professor in the Department of Epidemiology, Johns Hopkins and the Center for Disease Dynamics, United States

Stacy Sneeringer, Senior Research Economist, Economic Research Service United States Department of Agriculture USDA, United States

Dr Max Søgaard, Director process dev, ExpreS2ion Biotechnologies, Denmark

Thomas Sorensen, Senior Manager, Cold Chain, Supply Division, Unicef, Denmark

Bruno Speder, Head of Clinical Regulatory Affairs, SGS – Life Science Services, Belgium

Dr Erin Spiegel, Regulatory Affairs Manager, PharmaJet, United States

Dr Uwe Staerz, Chief Scientific Officer Chairman, Greffex Inc, United States

Dr Jens-Ulrich Stegmann, Vice President Head Clinical Safety and Pharmacovigilance, G.S.K Biologicals, Belgium

Mr Robert Steinglass, Director, Immunization Center, John Snow Inc, United States

Dr Dan Stinchcomb, CSO, Infectious Disease Research Institute, United States

Dr Koert Stittelaar, Director Preclinical Services, Viroclinics Biosciences, Netherlands

Dr Jeffrey Stoddard, US Medical Affairs Lead for Zoster Vaccine, GSK Vaccines, United States

Dr Jeffrey Stoddard at World Vaccine Congress Washington 2018

Dr Walter Straus, Associate Vice President, Therapeutic Area Head, Clinical Safety and Risk Management, Merck Research Laboratories, United States

Dr Darrel Styles, Senior Staff Veterinarian, U.S.D.A. A.P.H.I.S. Veterinary Services, United States

Dr Kena Swanson, Senior Principal Scientist, Viral Vaccines, Research Lead, RSV, Pfizer, United States

Dr Kena Swanson at World Vaccine Congress Washington 2018

Dr Erich Tauber, Chief Executive Officer and Founder, Themis Bioscience, Austria

Samuel Thevasagayam, Deputy Director, Global Development, The Bill & Melinda Gates Foundation, United States

Samuel Thevasagayam at World Vaccine Congress Washington 2018

Dr Marta Tomasi, Post-doc researcher, Free University of Bozen Bolzano, Italy

Steven Townson, Principal Scientist, Clinical Research Oncology Early Development, Merck & Co, United States

Dr Vu Truong, Founder, Chief Executive Officer and Director, Aridis Pharmaceuticals, United States

Dr Sean Tucker, CSO and VP Research, Vaxart, United States

Dr Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines, United States

Thomas Verstraeten, Owner, P95, Belgium

Dr Matthias Von Herrath, Professor in Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, United States

Dr Thomas W Scott, Distinguished Professor, University of California Davis, United States

Dr Brian Ward, Medical Officer, Medicago, Canada

Jim Wassil, Vice President, Business Unit Lead, Vaccines, Global Health and Value, Pfizer, United States

Laurie Werner, Global Director, BID Initiative, PATH, United States

Dr Stephen Whitehead, Senior Associate Scientist, NIAID, NIH, United States

Dr Stephen Whitehead at World Vaccine Congress Washington 2018

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services, Switzerland

Edward Wilson, Director, Center for Health Logistics, John Snow Inc, United States

Dr Ashley Wivel, Executive Director, Global Clinical Safety and Risk Management, Global Safety Physician for Ebola Vaccine Program, Merck Research Laboratories, United States

Dr Yan-ping Yang, Senior Director, Head of Bioprocess R&D North America, Sanofi Pasteur, Canada

Dr Masahide Yano, Research Scientist, U.S. Food and Drug Administration, United States

Shahrzad Yavari, Program Director, Nexleaf Analytics, United States

Alan Young, CSO, Medgene Labs, United States

Darin Zehrung, Portfolio Leader of Vaccine and Pharmaceutical Delivery Technologies and Senior Technical Officer, Path, United States

Dr Robert Zolynas, Vice President, Bayer Animal Health, United States

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071